Thieme E-Books & E-Journals -
Back
Thromb Haemost 2015; 113(04): 719-727
DOI: 10.1160/TH14-06-0547
Coagulation and Fibrinolysis
Schattauer GmbH

Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis

Dolly A. Parasrampuria
1   Daiichi Sankyo Pharma Development, Edison, New Jersey, USA
,
Thomas Marbury
2   Orlando Clinical Research Center, Orlando, Florida, USA
,
Nobuko Matsushima
3   Daiichi Sankyo Co, Ltd., Tokyo, Japan
,
Shuquan Chen
1   Daiichi Sankyo Pharma Development, Edison, New Jersey, USA
,
Prachi K. Wickremasingha
4   Certified Consultant Pharmacists Inc., Chatham, New Jersey, USA
,
Ling He
1   Daiichi Sankyo Pharma Development, Edison, New Jersey, USA
,
Victor Dishy
1   Daiichi Sankyo Pharma Development, Edison, New Jersey, USA
,
Karen S. Brown
1   Daiichi Sankyo Pharma Development, Edison, New Jersey, USA
› Author Affiliations